The Medical Letter on Drugs and Therapeutics
FROM
ISSUE
1649
May 2, 2022
View Complete Issue         Table of Contents 2019 
Vazalore - A New Aspirin Formulation
Subscribers: Log in to read full article.  Not a subscriber?  Subscribe or purchase article.
Vazalore - A New Aspirin Formulation
May 2, 2022 (Issue: 1649)
The FDA has approved an over-the-counter (OTC) liquid-filled capsule formulation of aspirin (Vazalore – PLx Pharma). The manufacturer has been heavily promoting Vazalore with claims of fast, predictable absorption and antiplatelet activity and...more
The Medical Letter is a subscriber-funded nonprofit organization that publishes critical appraisals of new prescription drugs and comparative reviews of drugs for common diseases.

Would you like to read the rest of this article?  Gain access below.

Subscribe
Subscriptions to The Medical Letter on Drugs and Therapeutics include:
  • Print version published and mailed biweekly (26 issues/year)
  • Unlimited online access to current and past issues (1988 - present)
  • Mobile App
  • FREE online per issue CME/CE
Purchase this article:
Title: Vazalore - A New Aspirin Formulation
Article code: 1649b
 Electronic, downloadable article - $45


Gain access through your organization
Ask your librarian to consider an Institutional Subscription to The Medical Letter.